✦ LIBER ✦

The Armour Pharmaceutical Company and early commercial development of calcitonin

✍ Scribed by Bastian, James W.

Book ID: 122671593
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 228 KB
Volume: 16
Category: Article
ISSN: 0169-6009
DOI: 10.1016/0169-6009(92)90901-O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Voluntary disclosures of quoted pharmace

Voluntary disclosures of quoted pharmaceutical companies in Sweden and the UK: the development over the period 1984–98

✍ Gray, Sidney J.; Skogsvik *, Kenth 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 150 KB

A cell-based approach for the early asse

A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development

✍ A. Casartelli; M. Bonato; P. Cristofori; F. Crivellente; G. Dal Negro; I. Masott 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 462 KB

Supercritical fluid chromatography and s

Supercritical fluid chromatography and steady-state recycling: Phase appropriate technologies for the resolutions of pharmaceutical intermediates in the early drug development stage

✍ Tony Q. Yan; Carlos Orihuela; Jay P. Preston; Fang Xia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

[AAPS Advances in the Pharmaceutical Sci

[AAPS Advances in the Pharmaceutical Sciences Series] Formulating Poorly Water Soluble Drugs Volume 3 || Scientific and Regulatory Considerations for Development and Commercialization of Poorly Water-Soluble Drugs

✍ Williams III, Robert O.; Watts, Alan B.; Miller, Dave A. 📂 Article 📅 2011 🏛 Springer New York 🌐 English ⚖ 472 KB

This volume is intended to provide the reader with a breadth of understanding regarding the many challenges faced with the formulation of poorly water-soluble drugs as well as in-depth knowledge in the critical areas of development with these compounds. Further, this book is designed to provide prac

What are the obstacles and needs of proa

What are the obstacles and needs of proactive ergonomics measures at early product development stages? – An interview study in five Swedish companies

✍ Ann-Christine Falck; Mikael Rosenqvist 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 179 KB

5196409 Bisphosphonates, pharmaceutical

5196409 Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism: Eli Breuer, Gershon Golomb, Jerusalem, Israel assigned to Yissum Research Development Company of the Hebrew University of Jerusalem

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 87 KB